CHRS Coherus Oncology, Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 5, 2026
$1,16
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$1,0952-Wochen-Tief
$2,5752-Wochen-Hoch
Marktkapitalisierung (MRQ)
$179M
P/E (TTM)
-1.1
EPS (TTM)
$-1.06
Umsatz (TTM)
$51M
Ihre Abzeichen
52W-Spanne
$1–$3
Analystenbewertung
BUY
Kursziel
$8
P/E
-1.1
ROE
-146.3%
Nettogewinnmarge
-259.4%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
CHRS Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$1.16
Marktkapitalisierung (MRQ)
$179M
P/E (TTM)
-1.1
EPS (TTM)
$-1.06
Umsatz (TTM)
$51M
ROE (TTM)
-146.3%
52W-Spanne
$1–$3
CHRS Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Über Coherus Oncology, Inc. - Common Stock Unternehmensübersicht von Wikipedia
SektorHealthcare
BrancheBiotechnology
Mitarbeiter144
LandUS
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$42M2016-12-31 → 2025-12-31
EPS$1.432017-12-31 → 2025-12-31
Freier Cashflow·2016-12-31 → 2023-12-31
Nettogewinnmarge-259.4%2016-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | CHRS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -1.15-Jahres-Durchschnitt ≈-0.2 | ≈-0.2 | · | · | |
| P/S (TTM) | 3.55-Jahres-Durchschnitt ≈3.7 | ≈3.7 | 4.9 | Unterbewertet | |
| K/B (MRQ) | 2.95-Jahres-Durchschnitt ≈1.5 | ≈1.5 | 2.8 | Teurer | |
| Price / Cash Flow (Kurs / Cashflow) | -1.35-Jahres-Durchschnitt ≈-9.3 | ≈-9.3 | · | · | |
| Kurs / Materieller Buchwert (MRQ) | 4.3 | · | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | CHRS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -311.6%5-Jahres-Durchschnitt ≈-150.6% | ≈-150.6% | -609.2% | Spitzenklasse | |
| EBITDA Margin (EBITDA-Marge) | -426.4%5-Jahres-Durchschnitt ≈-149.6% | ≈-149.6% | -576.6% | Spitzenklasse | |
| Vorgewinnmarge (TTM) | -316.4%5-Jahres-Durchschnitt ≈-148.5% | ≈-148.5% | -233.1% | Im Einklang | |
| Nettogewinnmarge (TTM) | -259.4%5-Jahres-Durchschnitt ≈18.1% | ≈18.1% | -288.3% | Spitzenklasse | |
| ROA (TTM) | -41.9%5-Jahres-Durchschnitt ≈-15.6% | ≈-15.6% | -28.9% | Spitzenklasse | |
| ROE (TTM) | -146.3%5-Jahres-Durchschnitt ≈60.6% | ≈60.6% | -55.7% | Spitzenklasse | |
| ROIC | -296.9%5-Jahres-Durchschnitt ≈-68.8% | ≈-68.8% | -83.9% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | CHRS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 1.85-Jahres-Durchschnitt ≈2.1 | ≈2.1 | 7.9 | Geringe Liquidität | |
| Quick Ratio (MRQ) | 1.65-Jahres-Durchschnitt ≈1.8 | ≈1.8 | 6.1 | Geringe Liquidität | |
| Interest Coverage (Zinsdeckungsgrad) | -20.15-Jahres-Durchschnitt ≈-9.7 | ≈-9.7 | -42.5 | Starke Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | CHRS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 59.8%5-Jahres-Durchschnitt ≈-15.0% | ≈-15.0% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | -41.5%5-Jahres-Durchschnitt ≈-38.9% | ≈-38.9% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | -38.4% | · | · | · | |
| EPS YoY (EPS VjV) | 472.0% | · | · | · | |
| Net Income YoY (Nettogewinn YoY) | 489.4% | · | · | · | |
| EPS CAGR 5Y (EPS CAGR 5J) | -2.5% | · | · | · | |
| Net Income CAGR 5Y (Nettoergebnis CAGR 5J) | 4.9% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | CHRS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.15-Jahres-Durchschnitt ≈0.4 | ≈0.4 | 0.1 | Im Einklang | |
| Inventory Turnover (Lagerumschlag) | 3.75-Jahres-Durchschnitt ≈2.4 | ≈2.4 | · | · | |
| Receivables Turnover (Forderungsumschlag) | 0.75-Jahres-Durchschnitt ≈1.5 | ≈1.5 | 3.4 | Schwach | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$292.9K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-1.7%
Nächster Bericht
Nov 04, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 5, 2026 | $-0.13 | $-0.20 | 36.3% |
| 31. März 2026 | Mai 11, 2026 | $-0.25 | $-0.28 | 10.3% |
| 31. Dezember 2025 | $-0.34 | $-0.35 | 2.9% | |
| 30. September 2025 | $-0.33 | $-0.33 | 0.45% | |
| 30. Juni 2025 | $-0.34 | $-0.30 | -12.4% | |
| 31. März 2025 | $-0.35 | $-0.24 | -47.9% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $42M | $26M | $257M | $211M | $327M | $476M | $356M | $0 | $2M | $190M | $30M | $31M | |
| Cost of Revenue | $14M | $9M | $159M | $70M | $58M | $38M | $17M | · | · | · | · | · | |
| R&D Expense | $109M | $92M | $109M | $199M | $363M | $143M | $94M | $110M | $162M | $254M | $213M | $78M | |
| SG&A Expense | $101M | $125M | $192M | $198M | $170M | $139M | $137M | $94M | $71M | $52M | $36M | $18M | |
| Operating Expenses | $223M | $226M | $460M | $468M | $590M | $320M | $248M | $204M | $234M | $306M | $249M | $96M | |
| Operating Income | $-181M | $-200M | $-203M | $-257M | $-264M | $156M | $108M | $-204M | $-232M | $-116M | $-219M | $-65M | |
| Interest Expense | $9M | $11M | $41M | $32M | $23M | $21M | $18M | $10M | $10M | $8M | $33.0K | $4M | |
| Interest Income | $7M | $4M | $3M | $2M | $1M | $600.0K | $2M | $1M | · | · | · | · | |
| Other Non-op | $7M | $8M | $5M | $4M | $-283.0K | $554.0K | $3M | $5M | $3M | $-4M | $-5M | $-19M | |
| Pretax Income | $-183M | $-215M | $-238M | $-292M | $-287M | $136M | $93M | $-209M | $-238M | · | · | · | |
| Income Tax | $0 | $0 | $-380.0K | $0 | $0 | $3M | $3M | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $168M | $29M | $-238M | $-292M | $-287M | $132M | $90M | $-209M | $-238M | $-127M | $-223M | $-87M | |
| EPS (Basic) | $1.43 | $0.25 | $-2.53 | $-3.76 | $-3.81 | $1.85 | $1.29 | $-3.22 | $-4.48 | · | · | · | |
| EPS (Diluted) | $1.43 | $0.25 | $-2.53 | $-3.76 | $-3.81 | $1.62 | $1.23 | $-3.22 | $-4.48 | · | · | · | |
| Shares (Basic) | 117,143,457 | 114,553,537 | 94,162,637 | 77,630,020 | 75,449,632 | 71,411,705 | 69,679,916 | 65,034,827 | 53,133,620 | · | 37,125,617 | 8,520,100 | |
| Shares (Diluted) | 117,143,457 | 114,553,537 | 94,162,637 | 77,630,020 | 75,449,632 | 83,491,898 | 73,185,943 | 65,034,827 | 53,133,620 | · | · | · | |
| EBITDA | $-180M | $-110M | $-200M | $-257M | $-264M | $156M | $108M | $-204M | $-232M | $-116M | $-219M | $-64M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $89M | $126M | $103M | $64M | $417M | $541M | $178M | $72M | $127M | $125M | $158M | $150M | |
| Short-term Investments | $83M | · | $15M | $128M | · | · | $0 | $0 | · | · | · | · | |
| Receivables | $18M | $111M | $261M | $110M | $123M | $157M | $142M | $0 | · | $2M | $2M | $2M | |
| Inventory | $3M | $4M | $63M | $39M | $38M | $44M | $10M | $2M | · | · | · | · | |
| Prepaid Expense | $6M | $10M | $11M | $23M | $11M | $6M | $5M | $2M | $18M | $32M | $35M | $20M | |
| Other Current Assets | · | · | · | · | · | · | · | $83.0K | $142.0K | $3M | $3M | $2M | |
| Current Assets | $207M | $342M | $476M | $381M | $602M | $767M | $343M | $84M | $145M | $161M | $197M | $179M | |
| PP&E (Net) | $1M | $3M | $5M | $9M | $8M | $10M | $6M | $7M | $13M | $11M | $11M | $4M | |
| PP&E (Gross) | · | · | · | · | · | · | $22M | $20M | $23M | $17M | $14M | $6M | |
| Accum. Depreciation | · | · | · | $4M | $4M | $3M | $16M | $13M | $10M | $6M | $4M | $1M | |
| Goodwill | · | · | $943.0K | $943.0K | $900.0K | $943.0K | $943.0K | $943.0K | $943.0K | $943.0K | $943.0K | $943.0K | |
| Intangibles | $20M | $25M | $42M | $6M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Other Non-current Assets | $4M | $6M | $10M | $9M | $10M | $13M | $362.0K | $14.0K | $13.0K | $2M | $146.0K | $50.0K | |
| Total Assets | $258M | $449M | $630M | $481M | $679M | $842M | $409M | $99M | $163M | $178M | $212M | $187M | |
| Accounts Payable | $10M | $28M | $35M | $12M | $16M | $15M | $26M | $15M | $15M | $20M | $26M | $9M | |
| Accrued Liabilities | $20M | $60M | $105M | $50M | $48M | $27M | $17M | $7M | $7M | $28M | $24M | $11M | |
| Current Liabilities | $140M | $283M | $332M | $139M | $165M | $146M | $115M | $33M | $28M | $56M | $106M | $52M | |
| Capital Leases | $1M | $3M | $5M | $4M | $7M | $9M | $10M | $0 | · | · | · | · | |
| Deferred Tax | $1M | $1M | $1M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $20M | $29M | $13M | $3M | $750.0K | $1M | $0 | $2M | $2M | $2M | $2M | $347.0K | |
| Total Liabilities | $197M | $581M | $823M | $618M | $582M | $561M | $304M | $138M | $132M | $159M | $219M | $120M | |
| Long-term Debt | · | · | · | · | · | · | $74M | $0 | · | · | · | · | |
| Common Stock | $12.0K | $12.0K | $11.0K | $8.0K | $7.0K | $7.0K | $7.0K | $7.0K | $6.0K | $5.0K | $4.0K | $3.0K | |
| Paid-in Capital | $1.44B | $1.42B | $1.39B | $1.20B | $1.15B | $1.04B | $1.00B | · | · | · | · | · | |
| Retained Earnings | $-1.38B | $-1.55B | $-1.58B | $-1.34B | $-1.05B | $-763M | $-895M | $-985M | $-775M | $-537M | $-410M | $-187M | |
| AOCI | $-195.0K | $-275.0K | $-248.0K | $-249.0K | $-270.0K | $-270.0K | $-558.0K | $-282.0K | $-750.0K | $-630.0K | $-401.0K | $-525.0K | |
| Stockholders' Equity | $61M | $-132M | $-193M | $-137M | $98M | $281M | $105M | $-39M | $31M | $19M | $-6M | $67M | |
| Liabilities + Equity | $258M | $449M | $630M | $481M | $679M | $842M | $409M | $99M | $163M | $178M | $212M | $187M | |
| Shares Outstanding | 121,154,925 | 115,614,548 | 112,215,260 | 78,851,516 | 76,930,096 | 72,513,348 | 70,366,661 | 68,302,681 | 59,840,467 | 45,808,163 | 39,005,589 | 33,257,978 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $2M | $3M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $2M | $674.0K | |
| Stock-based Comp | $17M | $28M | $43M | $51M | $51M | $38M | $34M | $35M | $33M | $27M | $17M | $11M | |
| Deferred Tax | · | · | $-380.0K | · | · | · | $0 | $0 | $0 | · | · | · | |
| Amort. of Intangibles | $3M | $3M | · | · | · | · | · | · | · | · | · | · | |
| Restructuring | · | · | · | · | · | · | · | · | $4M | · | · | · | |
| Other Non-cash | $-325M | $-79M | $17M | · | · | · | · | · | · | · | · | $51M | |
| Operating Cash Flow | $-139M | $-20M | $-175M | $-241M | $-37M | $154M | $28M | $-159M | $-200M | $-253M | $-108M | $-24M | |
| CapEx | · | · | $286.0K | $2M | $1M | $7M | $2M | $789.0K | $5M | $7M | $6M | $3M | |
| Investing Cash Flow | $375M | $230M | $145M | $-167M | $-138M | $-14M | $-13M | $-1M | $-4M | $-7M | · | · | |
| Stock Issued | · | $1M | · | · | $41M | · | · | · | · | · | · | · | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | $2.0K | |
| Net Stock Activity | · | · | · | · | $41M | · | · | · | · | · | · | $-2.0K | |
| Financing Cash Flow | $-274M | $-187M | $70M | $54M | $52M | $224M | $89M | $105M | $207M | $226M | · | · | |
| Net Change in Cash | $-37M | $23M | $39M | $-354M | $-124M | $364M | $105M | $-55M | $2M | $-33M | $8M | $111M | |
| Taxes Paid | $36.0K | $-114.0K | $-118.0K | $40.0K | $1M | · | $2M | $0 | $0 | · | · | · | |
| Free Cash Flow | · | · | $-175M | $-243M | $-39M | $147M | $27M | $-160M | $-205M | $-259M | $-114M | $-27M | |
| Levered FCF | · | · | $-216M | $-276M | $-62M | $126M | $9M | · | · | · | · | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -429.5% | -41.8% | -79.0% | -121.7% | -80.8% | 32.9% | · | · | -14918.8% | -61.0% | -729.2% | -207.9% | |
| Net Margin | 398.4% | 10.7% | -92.5% | -138.2% | -87.9% | 27.8% | · | · | -15306.6% | -67.0% | -743.2% | -280.1% | |
| Pretax Margin | -434.2% | 10.7% | -92.6% | -138.2% | -87.9% | 28.5% | · | · | · | · | · | · | |
| EBITDA Margin | -426.4% | -41.1% | -77.8% | -121.7% | -80.8% | 32.9% | · | · | -14918.8% | -61.0% | -729.2% | -205.8% | |
| ROA | 47.5% | 5.3% | -42.9% | -50.3% | -37.8% | 21.1% | 35.3% | -159.8% | -139.7% | -65.2% | -111.7% | -74.3% | |
| ROE | 185.8% | -25.9% | 145.5% | 248.8% | -251.3% | 49.3% | 177.5% | 1598.2% | -930.7% | -1778.5% | -736.9% | 575.6% | |
| ROIC | -296.9% | · | 104.9% | 186.9% | -270.0% | 54.2% | 99.2% | · | · | · | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 1.2 | 1.4 | 2.7 | 3.6 | 5.3 | 3.0 | 2.5 | 5.1 | 2.9 | 1.9 | 3.5 | |
| Quick Ratio | 1.4 | 0.8 | 1.1 | 2.2 | 3.3 | 4.8 | 2.8 | 2.2 | 4.5 | 2.2 | 1.5 | 3.0 | |
| Interest Coverage | -20.1 | -4.1 | -5.0 | -7.9 | -11.5 | 7.4 | 6.1 | -21.1 | -24.3 | -14.5 | -6638.4 | -16.6 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.5 | 0.5 | 0.4 | 0.4 | 0.8 | · | 0.0 | 0.0 | 1.0 | 0.2 | 0.3 | |
| Inventory Turnover | 3.7 | 1.8 | 3.1 | 1.8 | 1.4 | 1.4 | · | · | · | · | · | · | |
| Receivables Turnover | 0.7 | 1.4 | 1.4 | 1.8 | 2.3 | 3.2 | · | · | · | 111.2 | 15.1 | 23.1 |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.50 | $-1.14 | $-1.72 | $-1.74 | $1.27 | $3.87 | $1.50 | $-0.56 | $0.53 | $0.53 | $-0.19 | $2.01 | |
| Revenue / Share | $0.36 | $2.32 | $2.73 | $2.72 | $4.33 | $5.70 | · | · | · | · | · | · | |
| Cash Flow / Share | $-1.18 | $-0.18 | $-1.86 | $-3.11 | $-0.50 | $1.85 | $0.39 | · | · | · | · | · | |
| Cash / Share | $0.73 | $1.09 | $0.92 | $0.81 | $5.42 | $7.46 | $2.52 | $1.06 | $2.12 | $3.20 | $4.76 | $4.52 | |
| EPS (TTM) | $1.43 | $0.25 | $-2.53 | $-3.76 | $-3.81 | $1.62 | $1.23 | $-3.22 | $-4.48 | $-3.43 | · | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 59.8% | -89.7% | 21.9% | -35.4% | -31.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -41.5% | -56.8% | -18.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -38.4% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 472.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -2.5% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 489.4% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 4.9% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $42M | $26M | $257M | $211M | $327M | $476M | $356M | $0 | $2M | $190M | $30M | $31M | |
| Net Income TTM | $168M | $29M | $-238M | $-292M | $-287M | $132M | $90M | $-209M | $-238M | $-127M | $-223M | $-87M | |
| Market Cap | $172M | $160M | $374M | $625M | $1.23B | $1.26B | $1.27B | $618M | $527M | $1.10B | $764M | $543M | |
| P/E | 1.0 | 5.5 | -1.3 | -2.1 | -4.2 | 10.7 | 14.6 | -2.8 | -2.0 | -8.2 | · | · | |
| P/S | 4.1 | 6.0 | 1.5 | 3.0 | 3.8 | 2.6 | 3.6 | · | 338.4 | 5.8 | 25.4 | 17.4 | |
| P/B | 2.8 | -1.2 | -1.9 | -4.5 | 12.6 | 4.5 | 12.0 | -16.0 | 16.5 | 53.5 | -123.0 | 8.1 | |
| P / Tangible Book | 4.2 | · | · | · | 13.2 | 4.5 | · | · | · | · | · | · | |
| P / Cash Flow | -1.2 | -7.8 | -2.1 | -2.6 | -32.8 | 8.2 | 44.7 | -3.9 | -2.6 | -4.3 | -7.1 | -22.7 | |
| P / FCF | · | · | -2.1 | -2.6 | -31.7 | 8.6 | 47.8 | -3.9 | -2.6 | -4.2 | -6.7 | -20.3 | |
| Earnings Yield | 100.7% | 18.1% | -76.0% | -47.5% | -23.9% | 9.3% | 6.8% | -35.6% | -50.9% | -12.2% | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $14M | $12M | $13M | $12M | $10M | $8M | $8M | $6M | $10M | $2M | $92M | $75M | $59M | $32M | $45M | $45M | |
| Cost of Revenue | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $2M | $1M | $85M | $33M | $25M | $17M | $14M | $35M | |
| R&D Expense | $21M | $22M | $31M | $27M | $26M | $24M | $21M | $22M | $21M | $28M | $26M | $26M | $23M | $34M | $29M | $46M | |
| SG&A Expense | $21M | $23M | $24M | $25M | $26M | $26M | $30M | $28M | $28M | $40M | $49M | $48M | $45M | $49M | $54M | $45M | |
| Operating Expenses | $47M | $48M | $59M | $56M | $56M | $53M | $53M | $53M | $50M | $70M | $160M | $107M | $93M | $100M | $97M | $126M | |
| Operating Income | $-32M | $-36M | $-46M | $-44M | $-45M | $-45M | $-45M | $-47M | $-40M | $-68M | $-69M | $-32M | $-35M | $-68M | $-51M | $-80M | |
| Interest Expense | $2M | $2M | $2M | $2M | $2M | $2M | $727.0K | $3M | $4M | $3M | $11M | $10M | $10M | $10M | $9M | $8M | |
| Other Non-op | $1M | $1M | $2M | $2M | $3M | $187.0K | $1M | $2M | $1M | $3M | $-129.0K | $2M | $2M | $2M | $2M | $1M | |
| Pretax Income | $-33M | $-37M | $-46M | $-45M | $-45M | $-47M | $-45M | $-48M | $-55M | $-68M | $-80M | $-40M | $-43M | $-76M | $-59M | $-87M | |
| Income Tax | · | · | · | · | · | · | · | · | · | · | $0 | $-380.0K | · | · | · | · | |
| Net Income | $-21M | $-38M | $-38M | $-36M | $298M | $-57M | $-51M | $-11M | $-13M | $103M | $-80M | $-40M | $-43M | $-76M | $-59M | $-87M | |
| EPS (Basic) | $-0.13 | $-0.28 | $-0.34 | $-0.31 | $2.57 | $-0.49 | $-0.46 | $-0.09 | $-0.11 | $0.91 | $-0.67 | $-0.41 | $-0.49 | $-0.96 | $-0.76 | $-1.11 | |
| EPS (Diluted) | $-0.13 | $-0.28 | $-0.34 | $-0.31 | $2.57 | $2.57 | $-0.46 | $-0.09 | $-0.11 | $0.91 | $-0.67 | $-0.41 | $-0.49 | $-0.96 | $-0.76 | $-1.11 | |
| Shares (Basic) | 154,816,912 | 136,398,303 | · | 116,229,170 | 116,077,710 | 115,857,780 | · | 115,210,091 | 114,819,965 | 112,749,306 | · | 97,738,509 | 87,269,614 | 79,268,853 | · | 77,746,895 | |
| Shares (Diluted) | 154,816,912 | 136,398,303 | · | 116,229,170 | 116,077,710 | 116,077,710 | · | 115,210,091 | 114,819,965 | 112,749,306 | · | 97,738,509 | 87,269,614 | 79,268,853 | · | 77,746,895 | |
| EBITDA | $-32M | $-36M | · | $-44M | $-45M | $-45M | · | $-6M | $-20M | $-42M | · | $-31M | $-34M | $-68M | · | $-80M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $83M | $115M | $89M | $103M | $217M | $82M | $126M | $98M | $159M | $260M | $103M | $80M | $73M | $16M | $64M | $287M | |
| Short-term Investments | $22M | $52M | $83M | $88M | $21M | · | · | · | · | · | $15M | $51M | $72M | $112M | · | · | |
| Receivables | $14M | $22M | $18M | $9M | $5M | $60M | $111M | $168M | $175M | $252M | $261M | $217M | $141M | $101M | · | $91M | |
| Inventory | $6M | $5M | $3M | $2M | $5M | $4M | $4M | $48M | $62M | $62M | $63M | $67M | $64M | $49M | · | $28M | |
| Prepaid Expense | $5M | $9M | $6M | $9M | $12M | $16M | $10M | $14M | $14M | $14M | $11M | $16M | $18M | $21M | · | $22M | |
| Current Assets | $134M | $206M | $207M | $461M | $380M | $310M | $342M | $369M | $558M | $627M | $476M | $444M | $385M | $316M | · | $448M | |
| PP&E (Net) | · | · | $1M | $2M | $2M | $2M | $3M | $3M | $3M | $4M | $5M | $6M | $7M | $8M | · | $10M | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | · | · | $900.0K | · | · | |
| Goodwill | · | · | · | · | · | · | · | · | · | · | $943.0K | $943.0K | · | · | · | · | |
| Intangibles | $19M | $19M | $20M | $21M | $23M | $24M | $25M | $25M | $27M | $28M | $42M | $17M | · | · | · | · | |
| Other Non-current Assets | $3M | $4M | $4M | $4M | $5M | $6M | $6M | $7M | $8M | $9M | $10M | $8M | $8M | $8M | · | $10M | |
| Total Assets | $191M | $266M | $258M | $517M | $439M | $371M | $449M | $505M | $675M | $764M | $630M | $584M | $470M | $402M | · | $551M | |
| Accounts Payable | $13M | $11M | $10M | $25M | $38M | $41M | $28M | $22M | $77M | $38M | $35M | $37M | $29M | $23M | · | $10M | |
| Accrued Liabilities | $15M | $15M | $20M | $13M | $14M | $46M | $60M | $61M | $61M | $116M | $105M | $67M | $42M | $32M | · | $86M | |
| Current Liabilities | $76M | $132M | $140M | $372M | $264M | $255M | $283M | $296M | $463M | $538M | $332M | $240M | $169M | $123M | · | $171M | |
| Capital Leases | $459.0K | · | $1M | · | · | · | $3M | · | · | · | $5M | · | · | · | · | · | |
| Deferred Tax | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | · | · | · | · | |
| Other Non-current Liabilities | $18M | $17M | $18M | $18M | $17M | $31M | $29M | $29M | $28M | $3M | $13M | $4M | $102.0K | $102.0K | · | $102.0K | |
| Total Liabilities | $130M | $187M | $197M | $429M | $320M | $555M | $581M | $593M | $759M | $845M | $823M | $717M | $644M | $599M | · | $648M | |
| Common Stock | $15.0K | $15.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $11.0K | $11.0K | $11.0K | $9.0K | $8.0K | · | $7.0K | |
| Paid-in Capital | $1.50B | $1.50B | $1.44B | $1.43B | $1.43B | $1.42B | $1.42B | $1.41B | $1.41B | $1.40B | $1.39B | $1.37B | $1.29B | $1.22B | · | $1.19B | |
| Retained Earnings | $-1.44B | $-1.42B | $-1.38B | $-1.35B | $-1.31B | $-1.61B | $-1.55B | $-1.50B | $-1.49B | $-1.48B | $-1.58B | $-1.50B | $-1.46B | $-1.42B | · | $-1.28B | |
| AOCI | $-281.0K | $-268.0K | $-195.0K | $-203.0K | $-275.0K | $-275.0K | $-275.0K | $-275.0K | $-272.0K | $-272.0K | $-248.0K | $-265.0K | $-297.0K | $-278.0K | · | $-270.0K | |
| Stockholders' Equity | $61M | $79M | $61M | $88M | $120M | $-183M | $-132M | $-88M | $-84M | $-82M | $-193M | $-134M | $-175M | $-197M | $-137M | $-97M | |
| Liabilities + Equity | $191M | $266M | $258M | $517M | $439M | $371M | $449M | $505M | $675M | $764M | $630M | $584M | $470M | $402M | · | $551M | |
| Shares Outstanding | 154,470,363 | 154,217,609 | 121,154,925 | 116,236,018 | 116,222,726 | 115,907,216 | 115,614,548 | 115,213,407 | 115,198,655 | 113,496,854 | 112,215,260 | 109,113,046 | 94,442,014 | 80,488,296 | 78,851,516 | 77,770,593 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $862.0K | $881.0K | $300.0K | $300.0K | $300.0K | $400.0K | $100.0K | $400.0K | $500.0K | $600.0K | $700.0K | $800.0K | $800.0K | $900.0K | $1M | $900.0K | |
| Stock-based Comp | $3M | $2M | $3M | $3M | $5M | $5M | $6M | $7M | $7M | $7M | $11M | $10M | $10M | $12M | $12M | $12M | |
| Amort. of Intangibles | $600.0K | $600.0K | $600.0K | $700.0K | $600.0K | $700.0K | $700.0K | $1M | $700.0K | $900.0K | · | · | · | · | · | · | |
| Other Non-cash | · | · | · | · | · | $25M | · | · | · | $-158M | · | · | · | · | · | · | |
| Operating Cash Flow | $-62M | $-58M | $-20M | $-46M | $-47M | $-26M | $29M | $-62M | $60M | $-47M | $-13M | $-54M | $-39M | $-69M | $-100M | $-37M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | · | $0 | $100.0K | $152.0K | · | $457.0K | |
| Investing Cash Flow | $30M | $31M | $-3M | $-67M | $463M | $-17M | $-542.0K | $444.0K | $28M | $203M | $35M | $51M | $41M | $18M | $-130M | $-457.0K | |
| Stock Issued | $0 | $54M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $54M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $144.0K | $54M | $8M | $2.0K | $-282M | $-264.0K | $231.0K | $-167.0K | $-188M | $887.0K | $366.0K | $11M | $54M | $4M | $7M | $49M | |
| Net Change in Cash | $-32M | $26M | $-14M | $-114M | $134M | $-44M | $28M | $-62M | $-101M | $157M | $23M | $7M | $57M | $-47M | $-223M | $11M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | $-69M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -226.0% | -293.7% | · | -383.1% | -443.6% | -597.9% | · | -9.0% | -31.6% | -55.2% | · | -42.9% | -58.8% | -208.9% | · | -177.1% | |
| Net Margin | -144.2% | -311.4% | · | -307.1% | 2903.9% | -744.4% | · | -15.2% | -19.9% | 133.5% | · | -53.2% | -73.0% | -233.5% | · | -190.8% | |
| Pretax Margin | -233.1% | -300.0% | · | -384.7% | -437.5% | -623.7% | · | -15.2% | -19.9% | 133.5% | · | -53.7% | -73.0% | -233.5% | · | -190.8% | |
| EBITDA Margin | -226.0% | -293.7% | · | -380.6% | -440.7% | -592.6% | · | -8.5% | -30.8% | -54.4% | · | -41.9% | -57.5% | -208.9% | · | -177.1% | |
| ROA | -6.5% | -12.0% | · | -7.0% | 53.4% | -10.0% | · | -2.0% | -2.3% | 17.6% | · | -7.0% | -8.4% | -15.2% | · | -13.4% | |
| ROE | -22.8% | 73.1% | · | 35709.6% | 1667.3% | 42.6% | · | 9.7% | 10.0% | -73.9% | · | 34.4% | 43.4% | 82.3% | · | -515.4% | |
| ROIC | · | · | · | · | · | · | · | · | · | · | · | 23.7% | · | · | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | 1.6 | · | 1.2 | 1.4 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.9 | 2.3 | 2.6 | · | 2.6 | |
| Quick Ratio | 1.6 | 1.4 | · | 0.5 | 0.9 | 0.6 | · | 0.9 | 0.7 | 1.0 | · | 1.5 | 1.7 | 1.9 | · | 2.2 | |
| Interest Coverage | -13.9 | -16.5 | · | -19.1 | -20.0 | -21.1 | · | -1.2 | -3.8 | -3.8 | · | -3.1 | -3.5 | -7.0 | · | -10.7 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.8 | 0.9 | · | 0.1 | 0.1 | 0.1 | · | 0.4 | 0.4 | 0.6 | · | 0.7 | 0.5 | 0.4 | · | 1.1 | |
| Receivables Turnover | 1.5 | 0.3 | · | 0.1 | 0.1 | 0.0 | · | 0.4 | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.3 | · | 0.4 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.39 | $0.51 | · | $0.76 | $1.03 | $-1.58 | · | $-0.76 | $-0.73 | $-0.72 | · | $-1.22 | $-1.85 | $-2.44 | · | $-1.25 | |
| Revenue / Share | $0.09 | $0.09 | · | $0.10 | $0.09 | $0.07 | · | $0.61 | $0.57 | $0.61 | · | $0.76 | $0.67 | $0.41 | · | $0.58 | |
| Cash Flow / Share | · | $-0.42 | · | · | · | $-0.22 | · | · | · | $-0.37 | · | · | · | $-0.87 | · | · | |
| Cash / Share | $0.54 | $0.75 | · | $0.89 | $1.87 | $0.71 | · | $0.85 | $1.38 | $2.29 | · | $0.74 | $0.77 | $0.20 | · | $3.69 | |
| EPS (TTM) | $-1.06 | $1.64 | · | $4.37 | $4.59 | $1.91 | · | $0.04 | $-0.28 | $-0.66 | · | $-2.62 | $-3.32 | $-3.48 | · | $-3.55 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $51M | $47M | · | $37M | $32M | $32M | · | $110M | $179M | $227M | · | $211M | $182M | $183M | · | $239M | |
| Net Income TTM | $-132M | $186M | · | $155M | $180M | $-131M | · | $-450.0K | $-29M | $-59M | · | $-217M | $-264M | $-271M | · | $-279M | |
| Market Cap | $216M | $261M | · | $191M | $85M | $94M | · | $120M | $199M | $271M | · | $408M | $403M | $551M | · | $747M | |
| P/E | -1.3 | 1.0 | · | 0.4 | 0.2 | 0.4 | · | 26.0 | -6.2 | -3.6 | · | -1.4 | -1.3 | -2.0 | · | -2.7 | |
| P/S | 4.2 | 5.6 | · | 5.1 | 2.7 | 3.0 | · | 1.1 | 1.1 | 1.2 | · | 1.9 | 2.2 | 3.0 | · | 3.1 | |
| P/B | 3.6 | 3.3 | · | 2.2 | 0.7 | -0.5 | · | -1.4 | -2.4 | -3.3 | · | -3.1 | -2.3 | -2.8 | · | -7.7 | |
| P / Tangible Book | 5.1 | 4.4 | · | 2.8 | 0.9 | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | · | -4.5 | · | · | · | -3.6 | · | · | · | -5.8 | · | · | · | -8.0 | · | · | |
| Earnings Yield | -75.7% | 97.0% | · | 266.5% | 627.9% | 236.7% | · | 3.9% | -16.2% | -27.6% | · | -70.0% | -77.8% | -50.9% | · | -36.9% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $42M | $26M | $257M | $211M | $327M |
| Betriebsgewinnmarge % | -429.5% | -41.8% | -79.0% | -121.7% | -80.8% |
| Nettoergebnis | $168M | $29M | $-238M | $-292M | $-287M |
| Verwässerte EPS | $1.43 | $0.25 | $-2.53 | $-3.76 | $-3.81 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 1.5 | 1.2 | 1.4 | 2.7 | 3.6 |
| Quick Ratio | 1.4 | 0.8 | 1.1 | 2.2 | 3.3 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | · | · | $-175M | $-243M | $-39M |
Institutionelle Eigentümer (13F) 161 Einreicher · $91.7M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
161
Gehaltener Wert
$91.7M
Neue Positionen
12
Geschlossene Positionen
19
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 12 (-32 vs. Vorquartal) | 19 (+12 vs. Vorquartal) | 61 (+14 vs. Vorquartal) | 45 (+8 vs. Vorquartal) | -1.8M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| BlackRock, Inc. | $16.804.642 | 12.003.316 | 18,34% | Aktien |
| VANGUARD GROUP INC | $14.241.029 | 10.028.893 | 15,54% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $8.329.286 | 5.949.490 | 9,09% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $5.161.010 | 3.685.567 | 5,63% | Aktien |
| SAMSARA BIOCAPITAL, LLC | $4.799.999 | 3.428.571 | 5,24% | Aktien |
| Kohlberg Kravis Roberts & Co. L.P. | $4.184.019 | 3.036.076 | 4,57% | Aktien |
| STATE STREET CORP | $3.335.227 | 2.382.305 | 3,64% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $3.163.177 | 2.259.412 | 3,45% | Aktien |
| CM Management, LLC | $2.940.000 | 2.100.000 | 3,21% | Aktien |
| Alyeska Investment Group, L.P. | $2.426.528 | 1.733.234 | 2,65% | Aktien |
| Hudson Bay Capital Management LP | $2.370.200 | 1.693.000 | 2,59% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $1.862.281 | 1.330.201 | 2,03% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.719.297 | 1.228.069 | 1,88% | Aktien |
| PANAGORA ASSET MANAGEMENT INC | $1.592.255 | 1.137.325 | 1,74% | Aktien |
| NORTHERN TRUST CORP | $1.581.259 | 1.129.470 | 1,73% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $1.422.387 | 1.015.991 | 1,55% | Aktien |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $1.260.000 | 899.999 | 1,37% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.236.836 | 883.454 | 1,35% | Aktien |
| UBS Group AG | $1.064.501 | 760.358 | 1,16% | Aktien |
| GOLDMAN SACHS GROUP INC | $842.905 | 602.075 | 0,92% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $788.278 | 563.056 | 0,86% | Aktien |
| STRS OHIO | $553.840 | 395.600 | 0,60% | Aktien |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $547.400 | 391.000 | 0,60% | Aktien |
| Invesco Ltd. | $495.491 | 353.922 | 0,54% | Aktien |
| Bank of New York Mellon Corp | $447.563 | 319.687 | 0,49% | Aktien |
| TWO SIGMA ADVISERS, LP | $436.792 | 307.600 | 0,48% | Aktien |
| BANK OF AMERICA CORP /DE/ | $423.540 | 302.528 | 0,46% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $375.011 | 221.900 | 0,41% | Aktien |
| Jefferies Financial Group Inc. | $352.800 | 252.000 | 0,38% | Aktien |
| Nuveen, LLC | $351.049 | 250.749 | 0,38% | Aktien |
| MORGAN STANLEY | $323.048 | 230.748 | 0,35% | Aktien |
| Tyche Wealth Partners LLC | $281.683 | 201.202 | 0,31% | Aktien |
| BARCLAYS PLC | $281.601 | 201.143 | 0,31% | Aktien |
| IEQ CAPITAL, LLC | $227.294 | 162.353 | 0,25% | Aktien |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | $223.986 | 159.990 | 0,24% | Aktien |
| RHUMBLINE ADVISERS | $199.296 | 142.361 | 0,22% | Aktien |
| ENVESTNET ASSET MANAGEMENT INC | $197.218 | 140.870 | 0,22% | Aktien |
| PVG ASSET MANAGEMENT CORP | $186.529 | 133.235 | 0,20% | Aktien |
| DEUTSCHE BANK AG\ | $178.669 | 127.621 | 0,19% | Aktien |
| XTX Topco Ltd | $172.896 | 123.497 | 0,19% | Aktien |
| CITADEL ADVISORS LLC | $162.120 | 115.800 | 0,18% | Verkaufsoption |
| Summit Financial, LLC | $160.805 | 114.861 | 0,18% | Aktien |
| WELLS FARGO & COMPANY/MN | $158.064 | 112.903 | 0,17% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $153.478 | 109.627 | 0,17% | Aktien |
| Shay Capital LLC | $147.456 | 105.326 | 0,16% | Aktien |
| Corient Private Wealth LP | $140.000 | 100.000 | 0,15% | Aktien |
| HSBC HOLDINGS PLC | $130.950 | 91.895 | 0,14% | Aktien |
| CWM, LLC | $118.876 | 70.341 | 0,13% | Aktien |
| MetLife Investment Management, LLC | $110.058 | 78.613 | 0,12% | Aktien |
| SEI INVESTMENTS CO | $107.281 | 76.629 | 0,12% | Aktien |
Aktivisten & 5%+-Eigentümer 2 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| KKR BIOSIMILAR L.P., KKR BIOSIMILAR GP LLC, KKR FUND HOLDINGS L.P., KKR FUND HOLDINGS GP LIMITED, KKR GROUP HOLDINGS CORP., KKR & CO. INC., KKR MANAGEMENT LLC, HENRY R. KRAVIS, GEORGE R. ROBERTS ×3 Einreichungen | 2. Dezember 2019 | · | Erste Einreichung | · | SEC |
| Sofinnova Venture Partners VII, L.P. (“SVP VII”), Sofinnova Management VII, L.L.C. (“SM VII”), Dr. Michael F. Powell (“Powell”), Dr. James I. Healy (“Healy”), Eric P. Buatois (“Buatois”) ×4 Einreichungen | 14. Februar 2018 | · | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 29 Insider · 10 Führungskräfte · 18 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Dennis M Lanfear | President & CEO | 29. Mai 2026 A | 1.048.235 | 0 | 0 | $0 |
| Bryan J Mcmichael | Chief Financial Officer | 29. Mai 2026 A | 133.736 | 0 | 0 | $0 |
| Mcdavid Stilwell | Chief Financial Officer | 31. Dezember 2023 F | 75.305 | 0 | 0 | $0 |
| Jean-Frederic Viret | Chief Financial Officer | 1. Februar 2021 M | 61.295 | 0 | 0 | $0 |
| Vincent R Anicetti | Chief Operating Officer | 6. Juli 2021 A | 124.790 | 0 | 0 | $0 |
| Paul Reider | Chief Commercial Officer | 20. Januar 2025 F | 82.069 | 0 | 0 | $0 |
| Vladimir Vexler | Chief Scientific Officer | 31. März 2023 F | 116.361 | 0 | 0 | $0 |
| Barbara K Finck | Chief Medical Officer | 10. September 2018 M | 37.043 | 0 | 0 | $0 |
| Peter K. Watler | Chief Technical Officer | 1. Februar 2018 A | 5.900 | 0 | 0 | $0 |
| Alan C. Herman | Chief Scientific Officer | 15. Dezember 2017 A | 50.460 | 0 | 0 | $0 |
| Michael Lee Ryan | Direktor | 5. Juni 2026 A | 30.000 | 0 | 0 | $0 |
| Jill O'Donnell-Tormey | Direktor | 5. Juni 2026 A | 30.000 | 0 | 0 | $0 |
| Charles W. Newton | Direktor | 5. Juni 2026 A | 30.000 | 0 | 0 | $0 |
| Lee Nisley Newcomer | Direktor | 5. Juni 2026 A | 30.000 | 0 | 0 | $0 |
| Ali J. Satvat | Direktor | 5. Juni 2026 A | 30.000 | 0 | 0 | $0 |
| Rita A Karachun | Direktor | 5. Juni 2026 A | 30.000 | 0 | 0 | $0 |
| Mats Wahlstrom | Direktor | 5. Juni 2026 A | 30.000 | 0 | 0 | $0 |
| Georgia Erbez | Direktor | 12. Juni 2025 A | · | 0 | 0 | $0 |
| Kimberly Jo Tzoumakas | Direktor | 3. Juni 2024 A | · | 0 | 0 | $0 |
| Mark Stolper | Direktor | 3. Juni 2024 A | · | 0 | 0 | $0 |
| Dr. James I. Healy | Direktor | 7. Januar 2022 A | 0 | 0 | 0 | $0 |
| MENDELSON ALAN C | Direktor | 21. Mai 2021 A | · | 0 | 0 | $0 |
| Mary T Szela | Direktor | 11. Januar 2021 A | 0 | 0 | 0 | $0 |
| Bryan V Lawlis | Direktor | 11. Januar 2021 A | · | 0 | 0 | $0 |
| Samuel R Nussbaum MD | Direktor | 11. Januar 2021 A | · | 0 | 0 | $0 |
| Christos Richards | Direktor | 10. Januar 2020 A | 63.836 | 0 | 0 | $0 |
| August J. Troendle | Direktor | 1. Februar 2018 A | 29.994 | 0 | 0 | $0 |
| FMR LLC | · | 8. August 2016 S | 361.594 | 0 | 0 | $0 |
| Daiichi Sankyo Company, LTD | · | 12. November 2014 C | 2.867.426 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 16 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,45% | 88.872 SH | 2. Oktober 2026 | Täglich |
| IWC · iShares Trust | 0,04% | 445.148 SH | 11. September 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,01% | 10.938 SH | 2. Oktober 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 750.573 SH | 19. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 76.202 SH | 19. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 206.382 SH | 2. Oktober 2026 | Täglich |
| RSSL · Global X Funds | 0,01% | 62.442 NS | 31. Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,01% | 3.158.896 SH | 11. September 2026 | Täglich |
| IWO · iShares Trust | 0,00% | 436.778 SH | 11. September 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 17.030 SH | 3. September 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,00% | 15.055 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 1.863.589 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 3.953.617 SH | 19. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 49.507 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 7.172 SH | 19. August 2026 | Täglich |
| IWN · iShares Trust | · | 737.019 SH | 11. September 2026 | Täglich |
CHRS Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 12 Analysten
KAUF
Median-Ziel
$8.50
+632,8%
4 33,3%
Starker Kauf
6 50,0%
Kauf
2 16,7%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
4 Analysten · 2026-10-03Mittelwert-Ziel $7.75 +568,1%
← Unter allen Zielen
Aktueller Preis $1.16
Tief$4.00
Mittelwert$7.75
Hoch$10.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| CHRS | $172M | 1.0 | 59.8% | 398.4% | 185.8% | · |
| WHWK | $114M | -7.3 | -72.5% | -288.3% | -13.4% | · |
| TRDA | $394M | -3.0 | -87.9% | -565.5% | -41.9% | · |
| ELDN | $114M | -2.9 | · | · | -69.4% | · |
| PYXS | $72M | -0.9 | -14.2% | -574.5% | -112.9% | · |
| CUE | $29M | -1.1 | 195.8% | -96.9% | -119.3% | · |
| NKTX | $131M | -1.3 | · | · | -31.1% | · |
| CNTN | $112M | -2.7 | · | · | -18.0% | · |
| ORGO | $658M | 34.5 | 17.0% | 6.6% | 13.9% | · |
| DTIL | $100M | -1.2 | -50.1% | -133.4% | -72.4% | · |
| ALXO | $61M | -0.6 | · | · | -225.0% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 5, 2026